全文获取类型
收费全文 | 5991篇 |
免费 | 448篇 |
国内免费 | 156篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 118篇 |
妇产科学 | 34篇 |
基础医学 | 1230篇 |
口腔科学 | 47篇 |
临床医学 | 302篇 |
内科学 | 2355篇 |
皮肤病学 | 181篇 |
神经病学 | 228篇 |
特种医学 | 44篇 |
外国民族医学 | 1篇 |
外科学 | 189篇 |
综合类 | 533篇 |
预防医学 | 181篇 |
眼科学 | 83篇 |
药学 | 570篇 |
5篇 | |
中国医学 | 119篇 |
肿瘤学 | 361篇 |
出版年
2024年 | 6篇 |
2023年 | 66篇 |
2022年 | 124篇 |
2021年 | 192篇 |
2020年 | 139篇 |
2019年 | 162篇 |
2018年 | 153篇 |
2017年 | 184篇 |
2016年 | 188篇 |
2015年 | 198篇 |
2014年 | 405篇 |
2013年 | 485篇 |
2012年 | 319篇 |
2011年 | 355篇 |
2010年 | 304篇 |
2009年 | 260篇 |
2008年 | 278篇 |
2007年 | 264篇 |
2006年 | 258篇 |
2005年 | 260篇 |
2004年 | 234篇 |
2003年 | 193篇 |
2002年 | 172篇 |
2001年 | 171篇 |
2000年 | 158篇 |
1999年 | 94篇 |
1998年 | 114篇 |
1997年 | 103篇 |
1996年 | 101篇 |
1995年 | 81篇 |
1994年 | 59篇 |
1993年 | 54篇 |
1992年 | 50篇 |
1991年 | 49篇 |
1990年 | 46篇 |
1989年 | 25篇 |
1988年 | 42篇 |
1987年 | 38篇 |
1986年 | 20篇 |
1985年 | 48篇 |
1984年 | 43篇 |
1983年 | 22篇 |
1982年 | 26篇 |
1981年 | 22篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 2篇 |
1976年 | 9篇 |
1966年 | 2篇 |
排序方式: 共有6595条查询结果,搜索用时 234 毫秒
11.
本实验用C_(57)BL/6j小鼠CFU-GM集落形成的方法观察了三种CSF和氢化可的松、锂盐及硒盐对CFU-GM的影响及其对IFN的CFU-GM抑制作用的阻断作用。结果表明,三种CSF能部分拮抗IFN的CFU-GM抑制效应;微量的硒酸钠,碳酸锂均可刺激CFU-GM增殖,并使IFN200IU抑制的CFU-GM产率提高200%以上;微量的氢化可的松也能部分阻断IFN的CFU-GM抑制。 相似文献
12.
Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: Clinical study of 26 cases 总被引:1,自引:0,他引:1
NOBUYUKI SUGIURA YUZOH SAKAI MASAAKI EBARA HIROYUKI FUKUDA MASAHARU YOSHIKAWA HIROMITSU SAISHO MASAO OHTO FUKUO KONDO 《Journal of gastroenterology and hepatology》1996,11(6):535-539
The clinical findings in 26 patients in whom hepatocellular carcinoma (HCC) was detected after the start of interferon (IFN) therapy for chronic hepatitis C were analysed. Histological study before IFN therapy showed that 34.6% of patients were categorized as stage 3 (septal fibrosis with architectural distortion; the 0–4 scale) and 80.8% demonstrated at least some evidence of septal fibrosis or more advanced features. The AFP levels examined before IFN therapy were more than 20 ng/mL in 13 patients (84.6% of those studied). One of 26 patients had a complete response to IFN therapy, while six of 26 patients had only a partial response. HCC was detected within 1 year after the start of IFN therapy in 76.9% of patients. Thus, the possibility of the early occurrence of HCC or its existence at the time of therapy should be seriously considered when IFN therapy is contemplated. Patients with stage 3 or 3–4 histology may already have a small undetectable HCC before IFN therapy. Thus, for this reason, every patient treated with IFN should be examined at short regular intervals for the development of HCC during and after IFN therapy. 相似文献
13.
14.
15.
16.
Gordana Kocic Gordana Bjelakovic Dusica Pavlovic Tatjana Jevtovic Voja Pavlovic Dusan Sokolovic Jelena Basic Snezana Cekic Tatjana Cvetkovic Radivoj Kocic Svetlana Stojanovic 《Hepatology research》2007,37(8):637-646
Aim: Fas membrane-associated polypeptide antigen is a receptor molecule responsible for apoptosis-mediated signals. In animal models of acute viral hepatitis, apoptosis of hepatocytes is mediated by Fas-death receptors; therefore, the aim of this study was to evaluate the effect of interferon (IFN)-alpha on apoptotic markers and nuclease activity against different coding and non-coding single and double stranded RNAs during Fas-induced liver apoptosis. Methods: An in vivo experiment was performed with simultaneous administration of anti-Fas (CD95) antibodies and IFN-alpha, and an in vitro experiment was performed in hepatocyte cultures treated with anti-Fas antibodies and IFN-alpha. Results: Detection of apoptosis using Annexin V-FITC/propidium iodide, Bcl-2 and Bax expression in hepatocyte cultures confirmed the appearance of early apoptotic events and progression toward late apoptosis after anti-Fas antibody treatment. IFN-alpha had a tendency to retard the apoptosis process in Fas-induced apoptosis by increasing the number of viable cells and decreasing the number of cells in late apoptosis, by increasing the percentage of Bcl-2 positive cells, by decreasing the percentage of Bax positive cells, and by decreasing the nuclease activity compared to the anti-Fas antibody treated group. Total DNA and RNA concentration was much reduced in the Fas group and DNA fragmentation assay provided evidence for increased DNA degradation. Enhanced nuclease activity against DNA, rRNA, poly(A), poly(C), poly(U), poly(I:C), and poly(A:U) was manifested in the anti-Fas antibody treated group, except for the inhibitory-bound alkaline RNase. Conclusions: The results demonstrate that the RNA-degrading pathway in Fas-induced apoptosis can accelerate the liberation of the latent enzyme from the inhibitor complex. IFN-alpha prevented enormous, Fas-ligand induced degradation of all the substrates used in this experimental study, most probably due to similarities in the signal transduction pathways. Investigations of death receptor-induced apoptosis may lead to novel treatment combinations for patients with acute or chronic liver diseases. 相似文献
17.
F. Noventa G. L. De Salvo L. Chemello P. Pontisso A. Alberti 《Journal of viral hepatitis》1997,4(3):193-198
Interferon therapy is used widely for chronic hepatitis C but only a minority of treated patients achieve a long-lasting sustained response. We have developed, by logistic regression, a mathematical model to estimate the probability of sustained response in an individual patient with chronic hepatitis C when treated with interferon-α (IFN-α). The model, which includes age, sex, disease duration, pretreatment serum γ-glutamyl-transpeptidase, alanine aminotransferase and virus genotype, was developed from a database of 307 patients and validated in a new set of 200 patients. It performed well as goodness-of-fit ( P = 0.71 and P = 0.15 in the development and test sample, respectively) and discrimination (area under receiver operating curve = 0.79 in the development and 0.78 in the test sample, respectively). This model may provide decision support in the treatment of chronic hepatitis C with IFN-α. 相似文献
18.
Summary We analysed long-term follow-up results of 175 patients with malignant glioma (110 glioblastoma and 65 anaplastic astrocytoma) treated under five different regimes during the past two decades. The factors of age (less than 40), histology (anaplastic astrocytoma) and type of adjuvant therapy (radiation and chemotherapy) contributed to long survival. The other important factor was the response to adjuvant therapy.Cases of gross total removal or complete response (CR) of a residual tumour to an adjuvant therapy showed a better prognosis. The three and five year survival rate was 42% and 24%, respectively. The highest CR ratio (23%) was seen in patients treated by intravenous injection of interferon and ACNU in addition to radiotherapy (IAR therapy). 相似文献
19.
Rui T Marinho Ruth M Pinto Maria L Santos Miguel Carneiro de Moura 《Liver international》2004,24(5):413-418
BACKGROUND: Seroreversion, negativation of anti-hepatitis C virus previously positive, is sometimes found in some chronic hepatitis C-sustained responders (SRs) to antiviral therapy. AIMS: To determine the probability of seroreversion in SR treatment with Interferon and Ribavirin, and lymphocyte T helper (CD4+) reactivity to HCV antigens. METHODS: Thirty SR were followed on average for 54.8 months. Anti-HCV was tested by third generation test. Peripheral blood mononuclear cells (PBMCs) were isolated from venous blood and cultured to evaluate CD4+ proliferation in response to 2 microg/ml of eight HCV recombinant antigens from core, NS3, NS4, NS5 regions. RESULTS: Seroreversion was verified in 23% of patients (7/30), appearing at 47.5+/-24.0 months. The probability of anti-HCV loss in this group was 25% at 56 months after ending therapy. In 57% (4/7), anti-HCV returned to positive. These 7 SR patients with seroreversion also showed weaker CD4+ reactivity in 5% of tests (3/56) than the remaining 23 anti-HCV-positive SRs who showed stronger reactivity in 18% of tests (33/184), P=0.036. CONCLUSIONS: One-quarter of the SR showed seroreversion of anti-HCV and weaker CD4+ specific HCV proliferation than those who remained anti-HCV positive. The data suggest that complete viral eradication is a possible and achievable clinical objective. 相似文献
20.
J Dissemond D Haberer T Franckson U Hillen 《Journal of the European Academy of Dermatology and Venereology》2004,18(5):611-613
The Van der Woude syndrome is a rare autosomal dominant developmental malformation usually associated with bilateral lower lip pits. These congenital lip pits appear clinically as a malformation in the vermilion border of the lip, with or without excretion. As a genetic defect has been identified as a microdeletion of chromosome bands 1q32-q41, genetic counselling of patients may be considered. A nonsense mutation in the interferon regulatory factor-6 (IRF-6) is discussed as a pathogenic relevant factor. Therapeutic intervention is generally not necessary, although surgical excision is especially indicated in patients with recurrent inflammation. Physicians should be aware of the Van der Woude syndrome because it has been reported to be associated with a variety of malformations or other congenital disorders. 相似文献